Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.
Recruiting · NCT06227611 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fondazione G.B. Bietti, IRCCS
View the official record on ClinicalTrials.gov →What this trial is about
The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- glaucoma patients with glaucomatous optic nerve head defect and reduced ganglion cell layer thickness
Exclusion criteria
- age\<18 years
- unable to read, understand and sign the written informed consent
- unable to perform visual field test
- advanced glaucoma with C/D\>0.7
- other causes of optic neuropathies
- retinal or macular diseases
- lens or corneal opacities
- spherical refractive defect \>± 6D
- cylindric refractive defect \>± 3D
Where it is running
2 locations listed.
- IRCCS-Fondazione GB Bietti - Rome, Italy
- University of Rome Tor Vergata - Rome, Italy